These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29481766)

  • 1. Knowing and telling: how African-Australians living with chronic hepatitis B understand hepatocellular carcinoma risk and surveillance.
    Allard N; Emery J; Cowie B; Furler J
    Aust J Prim Health; 2018 May; 24(2):141-148. PubMed ID: 29481766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation.
    Robotin MC; Kansil MQ; George J; Howard K; Tipper S; Levy M; Phung N; Penman AG
    BMC Health Serv Res; 2010 Jul; 10():215. PubMed ID: 20663140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "one stop liver shop" approach improves the cascade-of-care for Aboriginal and Torres Strait Islander Australians living with chronic hepatitis B in the Northern Territory of Australia: results of a novel care delivery model.
    Hla TK; Bukulatjpi SM; Binks P; Gurruwiwi GG; Dhurrkay RG; Davies J
    Int J Equity Health; 2020 May; 19(1):64. PubMed ID: 32381081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors.
    Li ZQ; Hu CL; Yu P; Gu XY; Zhang JJ; Li H; Zhang HY; Lv J; Liu YM; Zeng QL; Yan JY; Yu ZJ; Zhang Y
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):311-318. PubMed ID: 28237828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir.
    Papatheodoridis GV; Dalekos GN; Yurdaydin C; Buti M; Goulis J; Arends P; Sypsa V; Manolakopoulos S; Mangia G; Gatselis N; Keskın O; Savvidou S; Hansen BE; Papaioannou C; Galanis K; Idilman R; Colombo M; Esteban R; Janssen HL; Lampertico P
    J Hepatol; 2015 Feb; 62(2):363-70. PubMed ID: 25195548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mixed-methods approach to understanding perceptions of hepatitis B and hepatocellular carcinoma among ethnically diverse Black communities in South Florida.
    Jones P; Soler J; Solle NS; Martin P; Kobetz E
    Cancer Causes Control; 2020 Dec; 31(12):1079-1091. PubMed ID: 32964364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.
    Li BA; Liu J; Hou J; Tang J; Zhang J; Xu J; Song YJ; Liu AX; Zhao J; Guo JX; Chen L; Wang H; Yang LH; Lu J; Mao YL
    World J Gastroenterol; 2015 Jan; 21(1):283-91. PubMed ID: 25574103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
    Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
    J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of chronic hepatitis B virus infection in Australia, 2011.
    MacLachlan JH; Allard N; Towell V; Cowie BC
    Aust N Z J Public Health; 2013 Oct; 37(5):416-22. PubMed ID: 24090323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1653 mutation in the enhancer II region of the hepatitis B virus genome in southern African Blacks with hepatocellular carcinoma.
    Welschinger R; Kew MC; Viana R; Badri M
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):541-5. PubMed ID: 20173647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis and hepatocellular carcinoma in African Americans.
    Reddy SI; Ukomadu C
    Cancer Epidemiol Biomarkers Prev; 2003 Mar; 12(3):248s-251s. PubMed ID: 12646520
    [No Abstract]   [Full Text] [Related]  

  • 12. The cascade of care for Australians living with chronic hepatitis B: measuring access to diagnosis, management and treatment.
    Allard NL; MacLachlan JH; Cowie BC
    Aust N Z J Public Health; 2015 Jun; 39(3):255-9. PubMed ID: 25716519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.
    Chayanupatkul M; Omino R; Mittal S; Kramer JR; Richardson P; Thrift AP; El-Serag HB; Kanwal F
    J Hepatol; 2017 Feb; 66(2):355-362. PubMed ID: 27693539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers.
    Mahfouz M; Nguyen H; Tu J; Diaz CR; Anjan S; Brown S; Bosire K; Carrasquillo O; Martin P; Jones PD
    Dig Dis Sci; 2020 Sep; 65(9):2551-2561. PubMed ID: 31813133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.
    Papatheodoridis GV; Sypsa V; Dalekos GN; Yurdaydin C; Van Boemmel F; Buti M; Calleja JL; Chi H; Goulis J; Manolakopoulos S; Loglio A; Voulgaris T; Gatselis N; Keskin O; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Idilman R; Esteban R; Janssen HLA; Berg T; Lampertico P
    J Hepatol; 2020 Jun; 72(6):1088-1096. PubMed ID: 31981727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening is associated with a lower risk of hepatocellular carcinoma-related mortality in patients with chronic hepatitis B.
    Su F; Weiss NS; Beste LA; Moon AM; Jin GY; Green P; Berry K; Ioannou GN
    J Hepatol; 2021 Apr; 74(4):850-859. PubMed ID: 33245934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative exploration of enablers for hepatitis B clinical management among ethnic Chinese in Australia.
    Xiao Y; Wallace J; Thompson A; Hellard M; van Gemert C; Holmes JA; Croagh C; Richmond J; Papaluca T; Hall S; Hong T; Demediuk B; Iser D; Ryan M; Desmond P; Visvanathan K; Howell J
    J Viral Hepat; 2021 Jun; 28(6):925-933. PubMed ID: 33662159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.
    Yuen MF; Wong DK; Fung J; Ip P; But D; Hung I; Lau K; Yuen JC; Lai CL
    Gastroenterology; 2008 Oct; 135(4):1192-9. PubMed ID: 18722377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of treating chronic hepatitis B: comparison of current treatment guidelines.
    Robotin M; Patton Y; Kansil M; Penman A; George J
    World J Gastroenterol; 2012 Nov; 18(42):6106-13. PubMed ID: 23155339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
    Jiang XY; Huang B; Huang DP; Wei CS; Zhong WC; Peng DT; Huang FR; Tong GD
    World J Gastroenterol; 2021 Mar; 27(11):1101-1116. PubMed ID: 33776376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.